Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
apn201 (1 trial)
apn01 (1 trial)
Cardiovascular Diseases (Phase 1)
Dermatitis (Phase 2)
Kidney Diseases (Phase 1)
Radiodermatitis (Phase 2)
Trials (2 total)
Trial APIs (2 total)